Ippolito Michael J, Gross Eric R, Abd-Elrahman Khaled S
Department of Neural Sciences, Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania (M.J.I.); Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine, Stanford University, Stanford, California (E.R.G.); Department of Anesthesiology, Pharmacology and Therapeutics and Djavad Mowafaghian Center for Brain Health, University of British Columbia, Vancouver, British Columbia (K.S.A.-E.); Department of Medical Sciences, College of Medicine and Health Science, Khalifa University, Abu Dhabi, United Arab Emirates (K.S.A.-E.); and Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (K.S.A.-E.).
Department of Neural Sciences, Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania (M.J.I.); Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine, Stanford University, Stanford, California (E.R.G.); Department of Anesthesiology, Pharmacology and Therapeutics and Djavad Mowafaghian Center for Brain Health, University of British Columbia, Vancouver, British Columbia (K.S.A.-E.); Department of Medical Sciences, College of Medicine and Health Science, Khalifa University, Abu Dhabi, United Arab Emirates (K.S.A.-E.); and Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt (K.S.A.-E.)
J Pharmacol Exp Ther. 2024 Oct 18;391(2):132-134. doi: 10.1124/jpet.124.002350.